Get Premium to unlock powerful stock data
NAS:BCYC (UK)  
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC

$ 18.47 +0.98 (+5.6%) 10:08 PM EST
P/E:
At Loss
P/B:
1.57
Market Cap:
$ 547.61M
Enterprise V:
$ 158.28M
Volume:
276.00K
Avg Vol (2M):
459.47K
Also Trade In:
Volume:
276.00K
Market Cap $:
547.61M
PE Ratio:
At Loss
Avg Vol (2-Month):
459.47K
Enterprise Value $:
158.28M
PB Ratio:
1.57
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Bicycle Therapeutics PLC
NAICS : 325412 SIC : 2834
B900, Babraham Research Campus, Cambridge, GBR, CB22 3AT
Description
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Name Current Vs Industry Vs History
Cash-To-Debt 8.65
Equity-to-Asset 0.72
Debt-to-Equity 0.14
Debt-to-EBITDA -0.63
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.17
Distress
Grey
Safe
Beneish M-Score -2.68
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.33
9-Day RSI 67.06
14-Day RSI 58.63
6-1 Month Momentum % -71.67
12-1 Month Momentum % -52.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.14
Quick Ratio 12.14
Cash Ratio 11.5
Days Sales Outstanding 74.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.7

Financials (Next Earnings Date:2022-08-05 Est.)

BCYC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BCYC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 13.749
EPS (TTM) ($) -2.89
Beta 0.66
Volatility % 72.38
14-Day RSI 58.63
14-Day ATR ($) 1.547234
20-Day SMA ($) 15.3605
12-1 Month Momentum % -52.3
52-Week Range ($) 12.08 - 62.075
Shares Outstanding (Mil) 29.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bicycle Therapeutics PLC Filings

Document Form Filing Date
No Filing Data

Headlines

See More